Friday, October 30, 2020
Home Life Style Health & Fitness India Major Contributor for 16 Million Fatal Lung Infection in 2015: Indian...

India Major Contributor for 16 Million Fatal Lung Infection in 2015: Indian Origin Researcher

  • RSV is a common and highly contagious virus that infects the respiratory tract
  • The study, reported in the journal Lancet, noted that there are more than 33 million cases of RSV infection in children under five each year worldwide
  • The findings highlight the pressing need for affordable treatments and vaccines as a priority to combat the virus

London, July 8, 2017: India, along with China, Nigeria, Pakistan and Indonesia, accounted for over 16 million or half of the global estimated cases of a fatal lung infection called Respiratory Syncytial Virus (RSV) in 2015, research led by an Indian-origin person have revealed.

RSV is a common and highly contagious virus that infects the respiratory tract, causing breathing difficulties and wheezing in most children before their second birthday.

The study, reported in the journal Lancet, noted that there are more than 33 million cases of RSV infection in children under five each year worldwide.

“We are at an opportune time to step up efforts to prevent RSV infection in young children. With more than 60 candidate vaccines in clinical development, it is likely that an RSV vaccine will be available in the next 5-7 years,” said lead researcher Harish Nair, Professor at the University of Edinburgh.

While around three million are admitted to hospital each year with the virus, more than 115,000 children under five are dying each year from complications associated with the infection.

Almost half of those who die in hospital are younger than six months old and more than 99 per cent of deaths occur in developing countries. Half of the RSV deaths in these countries occur outside the hospital, the study reported.

ALSO READ: “Dual-Disease Burden”? India’s Great Healthcare Challenge and Opportunity 

The findings highlight the pressing need for affordable treatments and vaccines as a priority to combat the virus.

For most babies and young children, RSV causes nothing more than symptoms of a cold but in some cases, however, it can lead to severe lung complications such as pneumonia or bronchiolitis.

“Our findings will provide better evidence to inform global funding priorities to accelerate vaccine development. It will assist policy makers and experts prepare for early introduction of this vaccine in developing countries,” Nair added.

For the study, the team analysed data from 329 studies of RSV infections worldwide. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,779FollowersFollow

Most Popular

New Trends of Hiring for Work in IT Industry

Each change is a step towards transformation. Ever since the pandemic interrupted our lives, the shift to remote working has not just altered the...

Making Orphaned and Abandoned Children Self-reliant

There are millions of orphan children across India, who lack the basic facilities required for survival. Having lost their parents at a very young...

Some Recovered COVID Patients Could Still Carry Virus

Researchers have reported that some patients recovered from COVID-19 could still carry the virus, suggesting that recovered patients should be more cautious and avoid...

Delayed Treatment of Brain Stroke Leads to Disabilities

Time is brain when it comes to the treatment of acute ischemic stroke. For every minute of delay in seeking treatment for a stroke,...

Foods that Reduce the Risks of Breast Cancer

A healthy lifestyle which includes exercise and a nutrient-dense diet may help reduce the risk of cancer. Foods that are rich in antioxidants and...

Delightful Golden Hues of Autumn in Switzerland

As beautiful as Switzerland is in summer, the changing colors of autumn paint the vistas of the country in delightful golden hues. Witnessing the...

Here’s How to Have a Better Digestive Health for Children

Has your toddler been refusing to poop in the toilet? Does he/she cry or make faces while passing stool or has the frequency of...

COVID Antibodies Respond at least for 5 Months, says Study

While some reports have come out saying antibodies to coronavirus go away quickly, a new study has revealed that the vast majority of individuals...

Recent Comments